Related Experiment Video
Updated: Oct 8, 2025

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde
Published on: November 11, 2022
Rapidly Self-Deactivating and Injectable Succinyl Ester-Based Bioadhesives for Postoperative Antiadhesion
Pengxu Wang1, Yuan Zhu2,3, Luyao Feng1
1Institute of Medical Engineering, Department of Biophysics, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
A novel self-deactivating bioadhesive, SEgel, prevents postoperative adhesions by selectively adhering to wounds. This innovation reduces complications and economic burden without causing unintended tissue bonding.
Area of Science:
- Biomaterials Science
- Surgical Innovation
- Tissue Engineering
Background:
- Postoperative adhesions cause significant patient complications and economic costs.
- Existing bioadhesives can lead to indiscriminate tissue adhesion, posing risks.
- Effective anti-adhesion barriers are crucial for improving surgical outcomes.
Purpose of the Study:
- To develop a novel bioadhesive with self-deactivating properties for postoperative antiadhesion.
- To address the challenge of indiscriminate tissue bonding associated with conventional bioadhesives.
- To create a stable yet transient barrier to prevent tissue adhesion.
Main Methods:
- Fabrication of a succinyl ester-based bioadhesive (SEgel) using poly(ethylene glycol) succinimidyl succinate (PEG-SS) and gelatin.
- Utilized N-hydroxysuccinimide esters (NHS-esters) for rapid covalent anchoring to tissue.
- Incorporated a fast-hydrolyzing superficial layer to achieve self-deactivation and prevent non-specific adhesion.
- Evaluated in vivo retention and biocompatibility, including foreign body reactions.
- Tested efficacy in cecum-sidewall and hepatic adhesion models.
Main Results:
- SEgel demonstrated rapid adhesion to target tissues via NHS-ester covalent bonds.
- The outward-facing layer rapidly hydrolyzed, losing adhesion within minutes and preventing indiscriminate bonding.
- The bioadhesive exhibited appropriate in vivo retention without adverse foreign body reactions.
- SEgel significantly reduced the severity of both cecum-sidewall and hepatic adhesions in animal models.
- The preparation process was straightforward, and raw materials showed good biocompatibility.
Conclusions:
- SEgel effectively prevents postoperative adhesions through controlled, self-deactivating adhesion.
- The bioadhesive overcomes the limitations of indiscriminate tissue bonding seen in other agents.
- SEgel represents a promising, biocompatible solution for preventing postoperative adhesions, enhancing patient safety and reducing healthcare costs.
More Related Videos
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Local Anesthetics: Chemistry and Structure-Activity Relationship
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...

